Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer
Schrauder MG et al
The Breast, April 2017Volume 32, Pages 186–191
Risk-reducing surgeries are a feasible option for mitigating the risk in individuals with inherited susceptibility to cancer, but are the procedures cost-effective in the current health-care system in Germany? This study compared the health-care costs for bilateral risk-reducing mastectomy (BRRM) and risk-reducing (bilateral) salpingo-oophorectomy (RRSO) with cancer treatment costs that could potentially be prevented.
